Company / Gross Margin
Vericel Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
74.4%
FY2025
5-year range
67.8% / 74.4%
FY2021-FY2025
Trend
+2.6%
vs FY2024
Sector context
#11 of 28
Health Care
What the data says
At 74.4%, Vericel's gross margin ranks #11 of 28 in the Health Care sector. Gross Margin has increased for 3 consecutive years, from 67.8% in FY2022 to 74.4% in FY2025.
Based on SEC 10-K filings.
74.4% in FY2025 with a 5-year CAGR of +9.8%.
Improved from 68.6% to 74.4% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +6.6pp
- 5-Year Change
- +9.8pp
- 10-Year Change
- -
Sector benchmark
#11 of 28 in Health CareTop 39% of 28This company 74.4% Sector average 60.3%
▼
+23.4% above sector average
Key checks
Key Insights
- Vericel's gross margin has grown for 3 consecutive years.
- In FY2025, gross margin increased 2.6% year-over-year.
- Currently 14.1pp above the Health Care sector average.
- Lowest gross margin in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 74.4% | +2.6% |
| FY2024 | 72.5% | +5.7% |
| FY2023 | 68.6% | +1.2% |
| FY2022 | 67.8% | -0.4% |
| FY2021 | 68.1% | +5.4% |
| FY2020 | 64.6% | +23.0% |
| FY2019 | 52.5% | +9.5% |
| FY2018 | 47.9% | -0.7% |
| FY2017 | 48.3% | +114.7% |
| FY2016 | 22.5% | -71.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026